BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24170546)

  • 21. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis.
    Kirane A; Ludwig KF; Sorrelle N; Haaland G; Sandal T; Ranaweera R; Toombs JE; Wang M; Dineen SP; Micklem D; Dellinger MT; Lorens JB; Brekken RA
    Cancer Res; 2015 Sep; 75(18):3699-705. PubMed ID: 26206560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells.
    Pénzes K; Baumann C; Szabadkai I; Orfi L; Kéri G; Ullrich A; Torka R
    Cancer Biol Ther; 2014; 15(11):1571-82. PubMed ID: 25482942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL.
    Lay JD; Hong CC; Huang JS; Yang YY; Pao CY; Liu CH; Lai YP; Lai GM; Cheng AL; Su IJ; Chuang SE
    Cancer Res; 2007 Apr; 67(8):3878-87. PubMed ID: 17440102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
    Uribe DJ; Mandell EK; Watson A; Martinez JD; Leighton JA; Ghosh S; Rothlin CV
    PLoS One; 2017; 12(7):e0179979. PubMed ID: 28727830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.
    Gjerdrum C; Tiron C; Høiby T; Stefansson I; Haugen H; Sandal T; Collett K; Li S; McCormack E; Gjertsen BT; Micklem DR; Akslen LA; Glackin C; Lorens JB
    Proc Natl Acad Sci U S A; 2010 Jan; 107(3):1124-9. PubMed ID: 20080645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
    Koorstra JB; Karikari CA; Feldmann G; Bisht S; Rojas PL; Offerhaus GJ; Alvarez H; Maitra A
    Cancer Biol Ther; 2009 Apr; 8(7):618-26. PubMed ID: 19252414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer.
    Mudduluru G; Vajkoczy P; Allgayer H
    Mol Cancer Res; 2010 Feb; 8(2):159-69. PubMed ID: 20145042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
    Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
    Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial.
    Richman SD; Seymour MT; Chambers P; Elliott F; Daly CL; Meade AM; Taylor G; Barrett JH; Quirke P
    J Clin Oncol; 2009 Dec; 27(35):5931-7. PubMed ID: 19884549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
    Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
    Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition.
    Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB
    Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
    Hector A; Montgomery EA; Karikari C; Canto M; Dunbar KB; Wang JS; Feldmann G; Hong SM; Haffner MC; Meeker AK; Holland SJ; Yu J; Heckrodt TJ; Zhang J; Ding P; Goff D; Singh R; Roa JC; Marimuthu A; Riggins GJ; Eshleman JR; Nelkin BD; Pandey A; Maitra A
    Cancer Biol Ther; 2010 Nov; 10(10):1009-18. PubMed ID: 20818175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.
    Choi YJ; Kim JH; Rho JK; Kim JS; Choi CM; Kim WS; Son J; Lee JC
    Oncol Rep; 2017 Apr; 37(4):2201-2208. PubMed ID: 28260071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells.
    Asiedu MK; Beauchamp-Perez FD; Ingle JN; Behrens MD; Radisky DC; Knutson KL
    Oncogene; 2014 Mar; 33(10):1316-24. PubMed ID: 23474758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer.
    Wang Y; Xia H; Zhuang Z; Miao L; Chen X; Cai H
    Cell Death Dis; 2014 May; 5(5):e1227. PubMed ID: 24832599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma.
    Liu J; Wang K; Yan Z; Xia Y; Li J; Shi L; Zou Q; Wan X; Jiao B; Wang H; Wu M; Zhang Y; Shen F
    PLoS One; 2016; 11(5):e0154767. PubMed ID: 27182739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma.
    Chen PX; Li QY; Yang Z
    Ann Diagn Pathol; 2013 Oct; 17(5):425-9. PubMed ID: 23707658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of astrocyte-elevated gene-1 indicates prognostic value of fluoropyrimidine-based adjuvant chemotherapy in resectable stage III colorectal cancer.
    Lin LW; Lai PS; Chen YY; Chen CY
    Pathol Int; 2021 Nov; 71(11):752-764. PubMed ID: 34528330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.